| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |